CX
Cindy Xiong
VCPartner, Foresite Capital
Cell engineering and CRISPR-focused biotech investor
San Francisco, CA2 notable investments
Series ASeries B+
BioHealthcareDeep Tech
Background
Cindy Xiong is a Partner at Foresite Capital, promoted in June 2024 after joining in 2019. She earned a PhD in Biology from the University of Michigan studying neural regeneration and was a Helen Hay Whitney postdoctoral fellow at UCSF in cell and genome engineering. She obtained an MBA in Healthcare Management from the Wharton School. Prior to Foresite, she was the first scientist at Agenovir, developing CRISPR-based therapeutics for HPV-induced cancers.
Investment Thesis
Gene therapy, cell engineering, and CRISPR platforms with strong scientific foundations addressing high-value therapeutic areas.
Investment Focus
Stages
Series ASeries B+
Sectors
BioHealthcareDeep Tech
Based in: San Francisco, CA (North America)
Notable Investments
Last updated: Jun 11, 2026